Feb 27, 2017 | Coding, Billing, and Collections, Compliance, Legal, and Malpractice, Digital Pathology, Instruments & Equipment, Laboratory Hiring & Human Resources, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Sales and Marketing, Laboratory Testing, Managed Care Contracts & Payer Reimbursement, Management & Operations
The DxMA Summit’s agenda will complement EWC’s and will explore disruptive technologies likely to be of great interest to medical laboratory leaders and pathology groups
Cybersecurity, wearable technology, and social media are the primary trends facing in vitro diagnostics (IVD) manufacturers and clinical laboratories.
That’s according to Debra Harrsch, President-elect of the Diagnostics Marketing Association (DxMA), a self-funded organization devoted to helping diagnostic marketing professionals stay abreast of industry trends and effectively navigate the changing legal, regulatory, and technology landscape.
DxMA will be holding its annual Global Marketing Summit April 30-May 1 at the Sheraton New Orleans Hotel on Canal Street. Coincidentally, the 2017 Executive War College (EWC) will takes place in the same venue, May 2-3, directly following the DxMA summit. (more…)
Feb 22, 2017 | Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
80% of US employers are using financial incentives in wellness programs, and Penn Medicine research suggests better incentive design is needed to get people to exercise
In recent years, there’s been plenty of headlines about wellness programs offered by employers and health insurers. Data show that such programs are cost-effective. But, until now, there were few studies about employees’ attitudes toward wellness programs. Because some of these wellness programs incorporate clinical laboratory testing, medical labs have a stake in their future.
The fact is that companies want healthier employees and they’re willing to pay for it. Experts say about 80% of US employers use financial incentives in worker wellness programs. And for each dollar a company spends on a wellness program, it saves about $3 in medical costs, according to an article the journal Health Affairs. (more…)
Feb 3, 2017 | Compliance, Legal, and Malpractice, Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Laboratory Sales and Marketing
Clinical laboratories and pathology groups can benefit from developing a strategy for addressing negative Yelp reviews
In today’s wired world, clinical laboratories and anatomic pathology groups have a new challenge: what to do when unhappy patients go to social networking sites and post comments about their negative experience with their lab. A lab can have a sterling reputation for service and it can all unravel if a vociferous and angry patient posts rants on the Internet.
Today’s reality is that, like them or not, online reviews posted on websites such as Yelp are here to stay. That is why medical lab managers and pathologists should know about a recent court ruling that protects websites that feature consumer reviews about businesses.
One business owner who sued such a website learned this out the hard way—in court. A locksmith in Redmond, Wash., reportedly filed a libel lawsuit, claiming he lost 95% of his business after receiving a negative 1-star review on Yelp. Regardless, a federal appeals court ruled that Yelp’s star rating system, which is based on user input, does not make Yelp responsible for negative reviews of businesses, the Chicago Tribune reported. (more…)
May 4, 2016 | Compliance, Legal, and Malpractice, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
The Wall Street Journal examines the FDA’s position on LDTs and looks at the pros and cons of LDT regulation by the federal agency
National news coverage over the deficiencies uncovered by Clinical Laboratory Improvement Amendments (CLIA) inspections of the clinical laboratory operated by Theranos in Newark, Calif., may have an interesting consequence that affects all medical laboratories and pathology groups.
Over the past 30 months, Theranos has regularly asserted that its laboratory-developed tests (LDTs) were under review by the Food and Drug Administration (FDA). For example, in an interview published in the December 14, 2014, issue of The New Yorker, Theranos Founder and CEO Elizabeth Holmes stated, “We believe that to realize our vision we must operate at the highest levels of excellence… And the FDA’s stamp of approval is seen as an indicator of the quality of a product.”
Thus, it would be ironic if the problems in the quality of clinical laboratory tests uncovered by federal CLIA inspectors at the Theranos lab facility in Newark was used by the FDA to justify their intent to regulate LDTs. The FDA has already released a report to the public that identified instances where laboratories running LDTs were alleged to have reported inaccurate lab test results to patients and their physicians. (more…)
Feb 26, 2016 | Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
This healthcare big data project’s tools and predictive models involve real-time monitoring of patient data and are expected to be available soon to other to providers
One healthcare big data project has begun to report progress on using predictive analytics to improve patient care in the diagnosis and management of such health conditions as sepsis and heart failure. This pioneering effort is being done at the University of Pennsylvania Health System’s (Penn Medicine’s), Institute for Biomedical Informatics (IBI).
What will be of high interest for pathologists and clinical laboratory executives is how this big data project incorporates lab test results into the effort.
Recently, Penn Medicine announced Penn Signals, a big-data project that, in part, relies on the lab data housed in the academic medical center’s laboratory information system (LIS) as well as its outpatient and inpatient data house in its electronic health record (EHR) system. (more…)
